Bharat Immunologicals & Biologicals (BOM:524663) E10: ₹-1.33 (As of Sep. 2023)


BOM:524663 Bharat Immunologicals & Biologicals Corp Ltd BOM:524663
4 GF Score
Price ₹16.65
View Full Analysis

What is Bharat Immunologicals & Biologicals E10?

Bharat Immunologicals & Biologicals BOM:524663 -0.89% 4 E10 is ₹-1.33 as of Sep. 2023. GuruFocus rates BOM:524663 with a GF Score™ of 4/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bharat Immunologicals & Biologicals's adjusted earnings per share data for the three months ended in Sep. 2023 was ₹-1.140. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-1.33 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-08), Bharat Immunologicals & Biologicals's current stock price is ₹16.65. Bharat Immunologicals & Biologicals's E10 for the quarter that ended in Sep. 2023 was ₹-1.33. Bharat Immunologicals & Biologicals's Shiller PE Ratio of today is .


Bharat Immunologicals & Biologicals  (BOM:524663) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bharat Immunologicals & Biologicals E10 Related Terms


Bharat Immunologicals & Biologicals E10 Historical Data

* Premium members only.

The historical data trend for Bharat Immunologicals & Biologicals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bharat Immunologicals & Biologicals E10 Chart

Bharat Immunologicals & Biologicals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.02 -0.63 -1.25

Bharat Immunologicals & Biologicals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.59 -1.00 -1.25 -1.32 -1.33

BOM:524663 vs VRTX, REGN, SGEN: E10 Comparison

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Immunologicals & Biologicals Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's Shiller PE Ratio falls into.


BOM:524663
4GF Score
Bharat Immunologicals & Biologicals Corp Ltd BOM:524663
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bharat Immunologicals & Biologicals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bharat Immunologicals & Biologicals's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-1.14/151.4920*151.4920
=-1.140

Current CPI (Sep. 2023) = 151.4920.

Bharat Immunologicals & Biologicals Quarterly Data

per share eps CPI Adj_EPS
201312 1.510 91.425 2.502
201403 1.030 91.425 1.707
201406 0.260 94.103 0.419
201409 -0.190 96.780 -0.297
201412 0.990 96.780 1.550
201503 -0.700 97.163 -1.091
201506 -0.730 99.841 -1.108
201509 -0.570 101.753 -0.849
201512 -0.160 102.901 -0.236
201603 0.020 102.518 0.030
201606 -0.090 105.961 -0.129
201609 0.360 105.961 0.515
201612 0.330 105.196 0.475
201703 0.998 105.196 1.437
201706 -0.310 107.109 -0.438
201709 -0.550 109.021 -0.764
201712 0.120 109.404 0.166
201803 -0.087 109.786 -0.120
201806 -0.190 111.317 -0.259
201809 -0.581 115.142 -0.764
201812 0.004 115.142 0.005
201903 -0.442 118.202 -0.566
201906 -0.800 120.880 -1.003
201909 -1.280 123.175 -1.574
201912 -0.540 126.235 -0.648
202003 0.872 124.705 1.059
202006 -0.180 127.000 -0.215
202009 -0.900 130.118 -1.048
202012 -0.440 130.889 -0.509
202103 -2.675 131.771 -3.075
202106 0.450 134.084 0.508
202109 -2.170 135.847 -2.420
202112 -0.080 138.161 -0.088
202203 -0.198 138.822 -0.216
202206 -1.160 142.347 -1.235
202209 -0.710 144.661 -0.744
202212 -1.080 145.763 -1.122
202303 -0.898 146.865 -0.926
202306 -1.060 150.280 -1.069
202309 -1.140 151.492 -1.140

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹-1.33 mean?
Bharat Immunologicals & Biologicals (BOM:524663) has a E10 of ₹-1.33 as of Sep. 2023. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bharat Immunologicals & Biologicals and its competitors.
Is Bharat Immunologicals & Biologicals' E10 too high?
Bharat Immunologicals & Biologicals' current E10 is ₹-1.33. Overall, Bharat Immunologicals & Biologicals has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Bharat Immunologicals & Biologicals' E10 compare to VRTX and REGN?
Bharat Immunologicals & Biologicals' E10 of ₹-1.33 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bharat Immunologicals & Biologicals and its competitors. Bharat Immunologicals & Biologicals's current E10 is ₹-1.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bharat Immunologicals & Biologicals stock overvalued right now?
Bharat Immunologicals & Biologicals (BOM:524663) has a current E10 of ₹-1.33. The current E10 is ₹-1.33. Bharat Immunologicals & Biologicals' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bharat Immunologicals & Biologicals (BOM:524663), the current E10 is ₹-1.33 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bharat Immunologicals & Biologicals Business Description

Address Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.
4GF Score

Get the complete analysis for BOM:524663

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹16.65
Price